The result of xCell suggested that scores of several types of T cells, including CD4+ T cells and CD8+ T cells, were significantly lower in BrM tumors when compared to primary lung cancer lesions (Additional file 2: Fig. S6b). The gene discussed is CD8A; the disease is lung carcinoma.